T H 2 cells is mediated through Notch signaling and Gata3 independent of IL-4. Gata3 mRNA is stabilized in Zc3h12a
The hallmark of asthma is bronchial hyperreactivity caused by T H 2 cell dysregulation. 1 T H 2 cytokines initiate and maintain key pathophysiologic features of asthmatic inflammation, with each cytokine exerting different functions in the induction of inflammation.
2,3 IL-4 plays a critical role in allergic sensitization and IgE production, 4 ,5 IL-5 is crucial for eosinophil survival, 6, 7 and IL-13 plays a central role in the development of airway hyperresponsiveness and tissue remodeling. 8, 9 T H 2 cytokine expression is controlled by transcription factors through multiple signaling pathways. T H 2 cells induce type 2 immunity characterized by high antibody titers and eosinophilia. [10] [11] [12] T H 2 cells can also be induced by parasitic helminths 13 and are shown to associate with atopic diseases, allergy, and asthma. 11, 14 Although the network of transcription factors required for activation and differentiation of T H 2 cells are well understood, [15] [16] [17] [18] [19] [20] how T H 2 development and Gata3 expression are negatively regulated, especially through posttranscriptional mechanisms, is largely unknown. Control of gene expression at the posttranscriptional level is a faster event than transcriptional control because of a direct targeting at the protein coding mRNA in the cytoplasm. 21, 22 Monocyte chemotactic protein-induced protein 1 (MCPIP1) encoded by the Zc3h12a gene was initially discovered as the most highly induced mRNA by monocyte chemotactic protein 1 in human peripheral blood monocytes. 23 MCPIP1 protein is highly expressed in the lymph nodes, thymus, and spleen 24, 25 and rapidly induced in macrophages on stimulation with inflammatory stimuli, such as TNF, IL-1b, and LPS. [25] [26] [27] MCPIP1 inhibits expression of proinflammatory cytokines (IL-1, IL-6, and IL-12) by binding to their 39 untranslated regions (UTRs) for mRNA degradation. MCPIP1 is also named Regnase-1 based on its RNase activity. 25 MCPIP1 reduction is required for Tcell activation. 28 Loss of MCPIP1 in CD4 T cells leads to severe splenomegaly and lymphadenopathy, suggesting that MCPIP1 is essential for inhibiting the development of lethal autoimmune responses. 24, 25 MCPIP1 functions through regulating mRNA decay and affecting nuclear factor kB signaling, 25, [29] [30] [31] leading to reduced expression of proinflammatory mediators. 24, 32 Therefore MCPIP1 is believed to be a key negative regulator involved in the control of inflammation and maintenance of immune homeostasis. Mice deficient in MCPIP1 have complex phenotypes, including autoimmune disorders, anemia, and severe inflammatory responses. 24, 25 In addition, it was recently reported that MCPIP1 can degrade viral RNA and thus acts as a host defense against viral infection. [33] [34] [35] MCPIP1 is also involved in controlling cytokine-induced endothelial inflammation 36 and inducing endothelial dysfunction. 37 Although MCPIP1 inhibits CD4 Tcell activation and cytokine production, 28, 30 it is largely unknown whether MCPIP1 plays a role in T H 2 development and T H 2 inflammation.
In this study we report that Zc3h12a 2/2 mice have spontaneous severe airway inflammation, with increased numbers of airway T H 2 cells capable of producing large amounts of IL-5. 
CD4
1 T cells into congenic CD45.1 mice induces severe T H 2 inflammation and accumulation of T H 2 cells in the airway of the recipient mice. Our study reveals that MCPIP1 regulates the development and function of IL-5-producing T H 2 cells through the Notch/Gata3 pathway. MCPIP1 represents a new and promising target for the treatment of asthma and other T H 2-mediated diseases.
METHODS Mice

Zc3h12a
1/2 mice were provided by Dr Pappachan E. Kolattukudy (University of Central Florida, Orlando, Fla). Homozygous Zc3h12a 2/2 mice were bred from Zc3h12a 1/2 breeding pairs and genotyped with PCR by detecting exons 4, 5, and 6, with a band of 300 bp indicating wild-type (WT) and 500 bp indicating knockout mice. The primer sequences are listed in Table E1 in this article's Online Repository at www.jacionline.org. Zc3h12a 2/2 mice and WT littermates were housed in pathogen-free conditions and used at 5 to 8 weeks of age. The CD45.1 congenic WT mice were used at 6 to 12 weeks of age. All mice were on a C57BL/6 background and housed in the animal facility at Saint Louis University. All mouse experiments were approved by the Institutional Animal Care and Use Committee of Saint Louis University (animal protocol no. 2443). In vitro T-cell differentiation Naive CD4 1 T cells were purified by using the EasySep Mouse Na€ ıve CD4 1 T Cell Negative Isolation Kit (catalog no. 19765; STEMCELLTechnologies, Vancouver, British Columbia, Canada). The purity of naive CD4 T cells was up to 95%. Naive CD4 T cells were treated with plate-coated anti-CD3 (2 mg/mL) and anti-CD28 (2 mg/mL) antibodies under the following conditions for 3 days: T H 1 conditions, anti-IL-4 (10 mg/mL) and IL-12 (10 U/ mL); T H 2 conditions, anti-IFN-g (10 mg/mL) and IL-4 (20 ng/mL); and T H 17 conditions, IL-6 (50 ng/mL), TGF-b (1 ng/mL), IL-23 (20 ng/mL), anti-IL-4 (10 mg/mL), and anti-IFN-g (10 mg/mL). Then cells were rested in fresh medium with IL-2 (1 ng/mL) for an additional 3 days. On day 6, cells were stimulated with phorbol 12-myristate 13-acetate (PMA; 50 ng/mL) and ionomycin (0.5 mg/mL) in the presence of monensin (GolgiStop; 0.7 mL/mL) for 4 hours for analysis of cytokines and surface markers by using flow cytometry. All antibodies are listed in Table E2 in this article's Online Repository at www.jacionline.org.
mRNA stability CD4 1 T cells were treated with plate-coated anti-CD3/CD28 antibodies for 4 hours and then stimulated with actinomycin D (5 mg/mL) and 5,6-dichlorobenzimidazole riboside (10 mg/mL) for different times. CEMTet-on cells expressing WT or mutant MCPIP1 were stimulated with doxycycline (100 ng/mL) for 24 hours and then treated with PMA and ionomycin for 3 hours and by using actinomycin D and 5,6-dichlorobenzimidazole riboside for different times. Total RNAs were collected, and cDNA was used to measure the remaining mRNAs for calculating half-life.
Murine models of allergic asthma
OVA (Sigma-Aldrich, St Louis, Mo) was adsorbed onto Imject Alum adjuvant (Pierce, Rockford, Ill) to a final concentration of 500 mg/mL. Mice were immunized intraperitoneally with 100 mg of OVA-alum or 10 mg of HDM extract (Dermatophagoides pteronyssinus; Greer Laboratories, Lenoir, NC) on day 0 and boosted with OVA on days 7 and 14 or with HDM on day 14. One week later, mice were challenged by means of intranasal injection of 25 mg of OVA or HDM extract in PBS per nostril daily for 5 days. On day 26, mice were killed, and lungs were fixed, sectioned, and stained with hematoxylin and eosin (H&E) and periodic acid-Schiff (PAS). Cells from draining lymph nodes were stimulated with OVA (0, 10, 50, or 250 mg/mL) or HDM extract (30 mg/mL) for 72 hours, and then supernatants were collected for measuring cytokines by using ELISA. Splenocytes were cultured with 200 mg/mL OVA or 30 mg of HDM extract in the presence of 10 ng/mL recombinant mouse IL-2 (eBioscience, San Diego, Calif). After 72 hours, CD4
1 T cells were isolated and resuspended in PBS. CD4 1 T cells (4 3 10 6 ) were injected intravenously into recipient mice, followed by administration of 50 mg of OVA or 50 mg of HDM extract intranasally daily for 5 times starting on days 3. Bronchoalveolar lavage fluid (BALF) was collected 1 day after the last challenge for assessment of inflammatory cell infiltration. Lung sections were stained with H&E and PAS and examined for pathologic changes (see the Methods section in this article's Online Repository at www.jacionline.org).
Statistical analysis
Data were analyzed with Prism software 5.0 (GraphPad Software, La Jolla, Calif). For standard data sets, an unpaired 2-tailed Student t test was used. (Fig 1, A) and PAS (Fig 1, B ; n 5 4). C and D, Cytokines in sera (Fig 1, C) and BALF (Fig 1, D) were measured by means of ELISA (3-4 mice in each group). E, Muc5ac and Gob5 mRNA expression in lung tissues was measured by using quantitative RT-PCR (n 5 3). F, Intracellular cytokine staining in lung infiltrates gated on CD4 1 T cells (summary of 3 to 5 mice per group). *P < .05, **P < .01, and ***P < .001.
RESULTS
MCPIP1-deficient mice display severe T H 2 inflammation in the airways
To test whether MCPIP1-deficient mice have airway inflammation, we stained lung sections with H&E and found a significant accumulation of inflammatory cells and airway remodeling in the lungs of Zc3h12a 2/2 mice compared with WT mice (Fig 1, A) . There were more mucin-positive cells (goblet cell metaplasia) in the lung epithelium of Zc3h12a 2/2 mice than in WT mice (Fig 1, B) . Total cell numbers in BALF were also significantly increased in Zc3h12a 2/2 mice compared with WT mice (see Fig E1 in this article's Online Repository at www.jacionline.org), indicating asthma-like airway inflammation in Zc3h12a 2/2 mice. Because T H 2 cytokines are critical for asthmatic inflammation, we measured the levels of T H 2 cytokines in BALF and blood. IL-5 and IL-13 levels in serum (Fig 1, C) and BALF (Fig 1, D) were much higher in Zc3h12a 2/2 mice than in WT mice, whereas IL-4 was undetectable in both (data not shown). When collecting BALF, we noticed a reduction in ''elastic recoil'' of the lungs of MCPIP1 knockout mice. Namely, we could retrieve hardly any PBS after 0.7 mL of PBS was injected into lungs of MCPIP1 knockout mice the first time. For the second flushing, we could only retrieve 0.1 to 0.3 mL of 0.7 mL of PBS. For the third and final flushing, we retrieved 0.4 to 0.5 mL of 0.7 mL of PBS. Altogether, we could only retrieve about 30% of the total PBS used for BALF flushing, and most of it was from the last flushing, which contained the lowest cytokine levels among 3 BALF.
We reason that the excessive T H 2 inflammation in the lungs of MCPIP1 knockout mice causes a reduction in lung elastic recoil and an increase in airway permeability, resulting in low cytokine levels in BALF from the MCPIP1 knockout mice. Nevertheless, even with the low cytokine levels in BALF, IL-5 and IL-13 levels were still significantly increased in MCPIP1 knockout mice compared with those in WT mice.
Expression of Muc5ac and Gob5 mRNA was also increased in the lungs of Zc3h12a 2/2 mice (Fig 1, E) . The increased IL-5 and IL-13 levels in Zc3h12a 2/2 mice compelled us to check T H 2 cells. Much more IL-5-and IL-13-producing CD4
1 T cells were presented in the lungs of Zc3h12a 2/2 mice than in WT mice, whereas IL-4-producing cells were minimally increased, and the cells producing IFN-g and IL-17A were comparable with or without anti-CD28 antibodies for 48 hours, and supernatants were used to detect cytokines by using ELISA (3 mice per group). *P < .05, **P < .01, and ***P < .001. (Fig 1, F) . These data indicate that MCPIP1 deficiency leads to an increase in IL-5/IL-13-producing T H 2 cells in the lung, which could cause asthma-like airway inflammation.
MCPIP1-deficient CD4 T cells produce significant amounts of T H 2 cytokines
In line with the role of MCPIP1 in preventing CD4 T-cell activation, 28 CD4 1 T cells deficient in MCPIP1 displayed a significant increase in effector T cells (CD62L lo CD44 hi ) compared with WT mice (see Fig E2, A, in this article's Online Repository at www.jacionline.org). Development of CD4 and CD8 T cells was similar between WT and Zc3h12a 2/2 mice (see Fig E2,  B) . To test whether Zc3h12a 2/2 CD4 1 T cells produce more T H 2 cytokines in vivo, we stimulated splenocytes with PMA/ ionomycin and then measured cytokine production. Percentages of IL-5-and IFN-g-producing effector CD4
1 T cells were increased in Zc3h12a 2/2 CD4 1 T cells compared with WT CD4 1 T cells (Fig 2, A) . Similar to lung CD4 T cells, splenic Zc3h12a 2/2 CD4 1 T cells also produced more IL-5 and IL-13 than WT CD4
1 T cells when stimulated with PMA/ionomycin (Fig 2, B and C) . Interestingly, when splenic CD4 T cells were activated with plate-bound anti-CD3/CD28 antibodies, production of IL-4, IFN-g, and IL-17 became comparable (Fig  2, D) .
Then we tested the responses of CD4 1 T cells to different strengths of T-cell receptor (TCR) signal. Maximal IL-5 and IL-13 production by Zc3h12a 2/2 CD4 1 T cells was induced even by low TCR signaling, whereas IL-4 production was caught up by WT CD4 1 T cells, and IFN-g production remained comparable (Fig 2, E , and see Fig E2, C) . These data indicate that once becoming effector cells, WT and Zc3h12a 2/2 CD4 1 T cells have similar capacity to produce cytokines, except IL-5 and IL-13, which are still overproduced in Zc3h12a 2/2 CD4 1 T cells. Indeed, IFN-g-producing cells were comparable between WT and Zc3h12a 2/2 effector T cells, whereas IL-5-producing cells remained increased among Zc3h12a 2/2 cells (see Fig E2, D) . Taken together, these data indicate that MCPIP1 regulates specifically IL-5/IL-13-producing T H 2 cells.
MCPIP1 regulates T H 2 cytokine production in a cell-intrinsic manner
Zc3h12a
2/2 CD4 1 T cells produce significant amounts of T H 2 cytokines, which might have an autocrine effect on T H 2 cytokine production. Therefore we cultured WT and Zc3h12a 2/2 CD4
1 T cells at a 1:1 ratio in the same well to let them be exposed first to the same levels of cytokines. This setting will exclude the possible effects of different levels of cytokines on T H 2 cytokine production in comparisons between WT and knockout cells. Numbers of IL-5-and IL-13-producing cells were significantly greater in Zc3h12a
), whereas numbers of IL-4-, IFN-g-, and IL-17-producing cells were comparable (Fig 3, A and B) . A and B, Numbers in outlined areas indicate percentages of cytokine-producing cells (Fig 3, A) and a summary of 3 to 4 mice per group (Fig 3, B) . C, mRNA expression in naive WT and Zc3h12a 2/2 CD4 1 T cells stimulated with anti-CD3/CD28 antibodies for 3 days (n 5 3). D, mRNA expression of cytokines in naive WT and Zc3h12a 2/2 CD4 1 T cells stimulated with anti-CD3/CD28 antibodies for 3 days, rested for 3 days, and restimulated with P/I for 4 hours (n 5 3). *P < .05, **P < .01, and ***P < .001.
Next, we measured the mRNAs of T H 2 cytokines and transcription factors important for T H 2 cell differentiation. Expression of T H 2-related transcription factor Gata3, Irf4, and Gfi mRNA was greater in Zc3h12a 2/2 CD4 1 T cells than in WT CD4 1 T cells (Fig 3, C) . Expression of the master transcription factors important for T H 17 cells (Rorc) and T H 1 (Tbx21) and regulatory T (Treg [Foxp3]) cells was reduced and slightly increased in Zc3h12a 2/2 cells, respectively (Fig 3, C) . mRNA expression of T H 2 cytokines (IL-4, IL-5, and IL-13) was increased in Zc3h12a 2/2 CD4 1 T cells, as was expression of Ifng and Il17a mRNAs, whereas Tgfb transcripts remained unchanged in Zc3h12a 2/2 CD4 1 T cells compared with those in WT CD4
1 T cells in response to anti-CD3/CD28 stimulation (Fig 3, D) . In addition, mRNAs encoding costimulatory molecules (Ox40l and Icosl) and chemokine receptors (Ccr3 and Cxcr4) associated with T H 2 cells were also highly expressed in Zc3h12a 2/2 CD4 1 T cells (see Fig E3 in this article's Online Repository at www.jacionline.org). Taken together, these data indicate an intrinsic effect for MCPIP1 on T H 2 cytokine production, especially IL-5 and IL-13.
MCPIP1 regulates IL-5-producing T H 2 cell differentiation under unfavorable conditions
To determine the effects of MCPIP1 on T H 2 cell development, we differentiated naive CD4 
CD4
T cells under nonpolarizing conditions, whereas this difference was abolished under T H 2-polarizing conditions (Fig 4, A-C).
However, naive Zc3h12a 2/2 CD4 1 T cells expressed much higher levels of IL-5 and IL-13 under both nonpolarizing and T H 2-polarizing conditions (Fig 4, B and C), indicating that naive Zc3h12a 2/2 CD4 1 T cells were programed to produce IL-5 and IL-13 once activated, even under unfavorable conditions. Indeed, higher levels of Il5, Il13, and Gata3 mRNA were detected in Zc3h12a 2/2 cells than in WT T cells under unfavorable T H 1-and T H 17-polarizing conditions (Fig 4, D) .
To define the role of IL-4 for IL-5 production in Zc3h12a
CD4
1 T cells, we added recombinant IL-4 and IL-4 neutralizing antibody, respectively, during expansion of Zc3h12a 2/2 CD4 1 T cells and found that neither adding IL-4 nor neutralizing IL-4 had any effect on IL-5 expression (Fig 4, E and F) . Neutralizing IL-4 inhibited the expression of IL-4 and Gata3 in non-IL-5-producing Zc3h12a 2/2 T cells (Fig 4, E and F) , suggesting that IL-4 is not required for the differentiation of IL-5-producing Zc3h12a 2/2 CD4 T cells. In addition, to confirm the role of MCPIP1 in T H 2 cytokine expression, we treated WTand Zc3h12a 2/2 CD4 1 T cells with MI-2, a specific inhibitor of MALT1 known to increase MCPIP1 levels by blocking its degradation, 28 and measured cytokine (Fig 4, C) and mRNA levels (Fig 4, D) , as in Fig 4, A and B, were measured and summarized (n 5 3-4). E, Naive Zc3h12a 2/2 CD4 1 T cells were stimulated with anti-CD3/ CD28 antibodies with anti-IL-4 (20 ng/mL), medium, or recombinant IL-4 (10 ng/mL) and stained for Gata3, IL-4, and IL-5 after PMA and ionomycin (P/I) treatment for 4 hours. F, Summary of 3 independent experiments, as in Fig 4 , E. *P < .05, **P < .01, and ***P < .001.
J ALLERGY CLIN IMMUNOL VOLUME 142, NUMBER 2 responses. Neither increasing MCPIP1 by means of MI-2 treatment nor deleting MCPIP1 affected IL-4 expression in CD4 1 T cells (see Fig E4, A, in this article's Online Repository at www.jacionline. org), further suggesting the independence of MCPIP1 in IL-4 expression. Increasing MCPIP1 by using MI-2 treatment inhibited IL-5 and IL-13 expression in WT CD4
1 T cells but not in Zc3h12a 2/2 CD4 1 T cells (see Fig E4, B and C). These data further indicate that MCPIP1 selectively regulates the development of IL-5/IL-13-producing T H 2 cells but not the IL-4-producing T H 2 cells.
Notch signaling mediates initiation of IL-5-producing T H 2 cells by MCPIP1 deficiency
Notch-mediated T H 2 cell differentiation and T H 2 immunity [38] [39] [40] are also IL-4 independent. Notch signaling is initiated by binding of Notch ligands to its receptors. There are 5 mammalian Notch ligands, 3 of which belong to the Deltalike (DLL) family (DLL1, DLL3, and DLL4) and 2 of which belong to the Jagged family (Jag1 and Jag2). 41 We found that expression of Jag1, Jag2, and DLL4 was increased in naive Zc3h12a 2/2 CD4 1 T cells compared with that in WT T cells (Fig 5, A) . To determine whether Notch signaling is involved, we pretreated naive Zc3h12a 2/2 CD4 1 T cells with g-secretase inhibitor (GSI), which blocks cleavage of the Notch intracellular domain from the membrane, stimulated the cells with anti-CD3/ CD28 antibodies, and then measured levels of T H 2 cytokines. IL-5 and IL-4 production were significantly inhibited, whereas IFN-g production enhanced after blocking Notch signaling by GSI (Fig 5, B and C) , demonstrating involvement of the Notch pathway in MCPIP1-mediated T H 2 inhibition. Next, we tested whether Notch signaling is required for cytokine production in effector T cells. We purified total CD4
1 T cells (most are and Zc3h12a 2/2 (CD45.2 1 ) mice were cultured in the same well at a 1:1 ratio with anti-CD3/CD28 antibodies and GSI for 3 days, rested for 3 days, and then stimulated with PMA and ionomycin (P/I) for 4 hours. Cytokine-producing cells were measured by means of fluorescence-activated cell sorting gating on either CD45.2 1 (Zc3h12a 2/2 ) or CD45.2 2 cells (WT). *P < .05, **P < .01, and ***P < .001.
effector cells) from Zc3h12a 2/2 mice, added GSI, and then measured levels of T H 2 cytokines and Gata3 expression. Blockade of the Notch pathway did not affect IL-5 and IL-4 production and Gata3 expression in Zc3h12a 2/2 effector CD4 T cells (Fig 5, D , and see Fig E5, A, in this article's Online Repository at www.jacionline.org).
Furthermore, we cocultured total WT and Zc3h12a 2/2 CD4 1 T cells in the same wells with or without GSI. Blockade of Notch signaling by GSI inhibited production of IL-4 and IL-13 in WT CD4
1 T cells but not in Zc3h12a 2/2 CD4 1 T cells, whereas IL-5 production was not affected by GSI in Zc3h12a 2/2 CD4 1 T cells. (Fig 5, E , and see Fig E5, B) . These data indicate that Notch mediates the initiation but not the maintenance of IL-5-producing T H 2 cells with MCPIP1 deficiency.
MCPIP1 targets Gata3 to control IL-5 production by T H 2 cells
Because Gata3 is the master transcription factor for T H 2 cell development, we checked Gata3 mean fluorescence intensity and found that Gata3 protein was highly expressed in Zc3h12a 2/2
CD4
1 T cells compared with WT CD4 1 T cells (Fig 6, A) . On the basis of Gata3 levels, we divided Zc3h12a 
Gata3
hi cells produced higher levels of IL-5 than Gata3 mid and Gata3 low cells (Fig 6, B) . To confirm whether Gata3 accounts for IL-5 overproduction in Zc3h12a 2/2 CD4 1 T cells, we knocked down Gata3 with Gata3-shRNA/lentivirus and found that Gata3 knockdown resulted in reduced IL-5 expression in a dose-dependent (Fig 6, H) or expressing mutant MCPIP1 (Fig 6, I) , and then Dox was added. Luciferase activity was determined in cell lysates (n 5 3). FSH, Forward scatter. *P < .05, **P < .01, and ***P < .001.
J ALLERGY CLIN IMMUNOL VOLUME 142, NUMBER 2 manner (Fig 6, C , and see Fig E6, A, in this article's Online Repository at www.jacionline.org), indicating that Gata3 mediates IL-5 production in Zc3h12a 2/2 T cells. In addition, we generated a human T-cell line (CEM) with an inducible MCPIP1 expression Tet-On system. Addition of doxycycline dose-dependently induced green fluorescent protein/MCPIP1 fusion protein expression in CEM/MCPIP1-Tet-On cells (see Fig E6, B) . As a consequence, expression of Gata3 protein (Fig 6, D) and mRNA (Fig 6, E, and see Fig E6, C) was reduced significantly. Because MCPIP1 is an RNase, 25 we measured the half-life of Gata3 mRNA and found that it was increased in Zc3h12a 2/2 CD4 1 T cells compared with WT CD4 1 T cells (Fig 6, F) and decreased in CEM/MCPIP1-TetOn cells after inducing MCPIP1 (Fig 6, G) . Expression of T H 2-related transcription factor Irf4 mRNA was also stabilized, and signal transducer and activator of transcription 6 (Stat6) mRNA was unaffected in Zc3h12a 2/2 CD4 1 T cells (see Fig E6, D) . These data indicate that MCPIP1 inhibits Gata3 mRNA expression through promoting its mRNA decay.
Fully differentiated T H 2 cells expressed high levels of Gata3
and low levels of MCPIP1 (see Fig E6, E) . To test whether MCPIP1 binds to Gata3 mRNA, we purified the MCPIP1-binding complex with anti-MCPIP1 antibody from cytoplasmic extracts of the T H 2 cells and then detected the bound mRNAs using RT-PCR. Compared with control values, Gata3 mRNA was enriched in the mRNAs pulled down with anti-MCPIP1 antibody (see Fig E6, F) , indicating a direct binding of MCPIP1 to Gata3 mRNA.
Next, we transfected a Gata3 39 UTR luciferase construct into CME-Tet-On cells, induced MCPIP1 by adding doxycycline, and then measured luciferase activity. Induction of MCPIP1 suppressed luciferase activity (Fig 6, H) , demonstrating that MCPIP1 promotes Gata3 mRNA decay through the 39 UTR. As shown in Fig E6, G, termates were sensitized and then challenged with OVA and killed on day 26. Cells isolated from draining lymph nodes were stimulated with different amounts of OVA for 72 hours, and cytokines in the supernatants were measured by means of ELISA (n 5 3). i.n., Intranasal; i.p., intraperitoneal. C, CD45.1 recipient mice were transferred with OVA-specific CD4 T cells as in Fig 7, B , and then challenged daily with OVA 5 times. H&E-stained lung sections of recipient mice were shown, and inflammation was scored. D, Eosinophil and neutrophil percentages in BALF of CD45.1 1 recipient mice after T-cell transfer were gated on Siglec-F and Ly6G (n 5 3). E, mRNA levels in lungs of recipient mice were measured by using quantitative RT-PCR (n 5 3). F, Percentages of CD44 1 CD45.1 2 (donor) CD4 T cells were measured in CD45.1 1 recipient mice. G, Intracellular IL-5 and IL-4 levels in donor cells were stained as in Fig 7, F , and gated on CD44 (n 5 3). *P < .05, **P < .01, and ***P < .001.
and then induced their expression by adding doxycycline, and measured luciferase activity. Induction of both WT and mutant MCPIP1, except the mutant D141N, inhibited luciferase activity (Fig 6, I ). We also measured expression of GATA3 mRNA in CEM-Tet-On cells after adding doxycycline. Consistent with the luciferase results, both WT and mutant MCPIP1, except the mutant D141N, inhibited endogenous GATA3 mRNA expression (see Fig E6, H) . Expression of GATA-3 protein displayed similar patterns after expressing WT and mutant MCPIP1 (see Fig E6, I ). To further confirm whether mutant D141N mediates Gata3 mRNA decay, we measured the halflife of GATA3 mRNA in the above CEM-Tet-On cells. The half-lives of GATA3 mRNA were shortened in cells expressing WT MCPIP1 but not in cells expressing the D141N mutants (see Fig E6, J) , indicating that the RNase domain is required for GATA3 mRNA degradation by MCPIP1. Taken together, these data demonstrate that MCPIP1, through RNase activity, destabilizes Gata3 mRNA and therefore inhibits IL-5 and IL-13 production by CD4 T cells.
MCPIP1 deficiency in CD4 T cells enhances T H 2-mediated inflammation in allergen-induced asthma models
To determine the physiologic consequence of MCPIP1-mediated T H 2 inhibition, we immunized WT and Zc3h12a
2/2
mice with OVA mixed with the adjuvant aluminum hydroxide and then challenged them with intranasal OVA (Fig 7, A) . One day after the last challenge, we stained lung tissue with H&E and PAS. Compared with WT mice, there were increased infiltrating inflammatory and mucin-positive cells (goblet cell metaplasia) in lungs of the Zc3h12a 2/2 mice (see Fig E7, A and B, in this article's Online Repository at www.jacionline.org).
Numbers of effector CD4
1 T cells were also increased after OVA immunization and challenge in both mice (see Fig E7, C) . In addition, IL-4-and IL-5-producing effector CD4 T-cell counts were highly increased in the lungs of Zc3h12a 2/2 mice compared with those in WT mice (see Fig E7, D) . In line with the results shown in Fig 2, Lung sections were stained with H&E and PAS, and inflammation was scored (n 5 3). C, Cells isolated from draining lymph nodes (LN) as in Fig 8 , B, were stimulated with HDM for 72 hours. IL-5 and IL-13 levels in supernatants were measured by using ELISA (n 5 3). D, WT B6 mice were transferred with HDM-specific CD4 T cells as in Fig 8, C , and then sensitized with HDM. Representative H&E-and PAS-stained lung sections were shown from the recipients received HDM-treated WT or Zc3h12a 2/2 cells, and inflammation was scored (5 mice in each group). E, Cells from lungs of recipient mice as in Fig 8, D, were stimulated with PMA and ionomycin (P/I) for 4 hours, and then RNA was extracted to measure mRNA expression by using quantitative RT-PCR (n 5 3). *P < .05, **P < .01, and ***P < .001.
IL-5 and IL-13 levels but not IL-4 levels than WT CD4
1 T cells in response to OVA stimulation in vitro (see Fig E7, E) . These data indicate that MCPIP1 inhibits OVA-specific CD4 T-cell responses in vivo through downregulating allergen-specific T H 2 inflammation mediated by IL-5 and IL-13.
To define whether Zc3h12a 2/2 T H 2 cells are pathogenic, we first expanded OVA-specific T cells by culturing splenocytes from the above OVA-immunized mice with OVA and IL-2. OVA-specific Zc3h12a 2/2 CD4 1 T cells secreted large amounts of IL-4, IL-5, and IL-13 in response to OVA stimulation, whereas IFN-g production was reduced (Fig 7, B) . Next, we purified the OVA-specific CD4
1 T cells and transferred them intravenously into congenic CD45.1 1 recipient mice. Three days after T-cell transfer, recipient mice were challenged with OVA for 5 days and then analyzed. Mice that received OVA-specific Zc3h12a 2/2
CD4
1 T cells displayed an increase in infiltrating immune cells and inflammation in the airways compared with mice received WT OVA-specific CD4 T cells (Fig 7, C) . Numbers of lung eosinophils (CD11b
were also increased in the mice receiving OVA-specific Zc3h12a 2/2 CD4 T cells compared with mice transferred with OVA-specific WT CD4 T cells (Fig 7, D , and see Fig E7, F) , indicating that Zc3h12a 2/2 CD4 T cells are pathogenic and can induce asthma-like airway inflammation.
Analyses of T H 2 cytokine transcripts revealed that Il5 and Il13 but not Il4 mRNA expression was increased in the lungs of mice receiving OVA-specific Zc3h12a 2/2 CD4 T cells (Fig 7, E) . The purity of donor cells was confirmed by checking CD3 and CD4 expression gated on CD45.1 and CD45.2 (see Fig E7, G) . In addition, Zc3h12a 2/2 donor CD4 T cells displayed enhanced proliferation and effector phenotypes (Fig 7, F) and produced increased IL-5 and IL-4 levels in vivo (Fig 7, G) .
Furthermore, we tested the effects of Zc3h12a 2/2 CD4 T cells with physiopathologically relevant HDM extracts. Zc3h12a 2/2 mice and WT littermates were sensitized and challenged with HDM, as shown in Fig 8, A. Lung inflammation and PASpositive cell counts were increased in Zc3h12a 2/2 mice compared with those in WT mice (Fig 8, B) . We next expanded HDM-specific CD4 T-cell counts with HDM and IL-2 and checked the HDM-specific responses. Zc3h12a 2/2 CD4 1 T cells produced significantly more IL-5 and IL-13 than WT CD4 1 T cells in response to HDM stimulation (Fig 8, C) . Then we transferred the HDM-specific CD4 1 T cells into WT B6 mice and challenged them with HDM. Mice receiving the HDM-specific Zc3h12a 2/2 CD4 1 T cells had more severe lung inflammation and more PAS-positive cells than the mice transferred with WT cells (Fig 8, D) . Expression of Il5 and Il13 was also increased in lungs of the mice that received knockout HDM-specific CD4 T cells (Fig 8, E) . Taken together, the results of the HDM model are consistent with those of the OVA model, indicating that CD4 T cells deficient in MCPIP1 exaggerate type 2-biased immune responses and cause T H 2 inflammation in the airway.
DISCUSSION
We provide several lines of evidence identifying MCPIP1 as a major negative regulator for T H 2 cell differentiation and effector function, especially IL-5/IL-13-producing T H 2 cells. We discovered enhanced IL-5
1 T H 2 differentiation and airway inflammation in MCPIP1-deficient mice. Mechanistically, we identified the Notch pathway and Gata3 as critical targets of MCPIP1 for regulating IL-5/IL-13-producing T H 2 cell development. CD4 1 T cells are polarized and differentiated into IL-5-producing T H 2 cells in the absence of MCPIP1. MCPIP1 also directly targets T H 2 cytokines for mRNA decay (data not shown). The preferential differentiation of naive Zc3h12a 2/2 CD4 T cells toward T H 2 but not T H 17 or Treg cells in vitro might be due to targeting several key transcription factors important for T H 2 cell differentiation, including Gata3, Gfi, and Irf4. The mRNAs of Rorc, Tbx21, and Foxp3 were not altered significantly in Zc3h12a 2/2 CD4 T cells.
IL-4 is a key cytokine for T H 2 differentiation. T cells deficient in MCPIP1 lead to IL-4 overproduction that might have an autocrine effect on T H 2 differentiation. However, we found that neutralizing IL-4 inhibited only IL-4 expression and had no effects on IL-5 expression in Zc3h12a 2/2 CD4 T cells, indicating that development of IL-5-producing Zc3h12a 2/2 T H 2 cells is independent of IL-4.
MCPIP1 also targets inducible costimulator and OX40, 28 which have been shown to be important for T H 2 differentiation. 42, 43 Most importantly, our data show that MCPIP1 directly targets the T H 2-specific transcript factor Gata3. Naive T cells express low levels of Gata3 induced by TCR and IL-4 receptor. 44 Zheng and Flavell 18 show that Gata3 was present in naive CD4 T cells and increased during T H 2 development and extinguished during T H 1 development. Gata3 can be induced in both IL-4-dependent and independent ways. 44 MCPIP1-deficient CD4 1 T cells express high levels of Gata3, even under nonpolarizing conditions, indicating that MCPIP1 is critical for naive CD4 T cells to maintain their nonpolarized phenotypes.
When MCPIP1 levels are reduced, CD4 T cells are more likely to polarize and differentiate into IL-5-producing T H 2 cells, leading to T H 2-associated inflammation. Type 2 innate lymphoid cells (ILC2s) share many features with Zc3h12a
2/2
T H 2 cells and also produce IL-13 and IL-5. [45] [46] [47] ILC2s are regulated by Gata3 and play an important role in allergic airway inflammation. [48] [49] [50] It will be of interest to see whether MCPIP1 regulates ILC2s as well.
The Notch pathway is important in T H 2 cell differentiation and activation. [51] [52] [53] [54] [55] Notch-mediated T H 2 cell differentiation and T H 2 immunity [38] [39] [40] are quite similar to the effects of MCPIP1 on IL-5/ IL-13-producing T H 2 cells; namely, both are independent of IL-4 and STAT6 (data not shown). Blockade of Notch signaling inhibits T H 2 cytokine production only in naive but not in effector Zc3h12a 2/2 CD4 T cells, suggesting that Notch signaling only controls the initiation of T H 2 cell differentiation mediated by MCPIP1. Because GSI blocks Notch intracellular domain cleavage from the membrane, this suggests that ligand-receptor interaction upstream of the intracellular Notch pathway mediates the effects of MCPIP1 on T H 2 cells. Indeed, expression of Notch ligands, Jag1/2, and Dll4 was increased in MCPIP1-deficient CD4 T cells (Fig 5, A) , suggesting that Jag1/2 and Dll4 might be involved in activation of surrounding Zc3h12a 2/2 CD4 T cells to attain the T H 2 phenotype.
Several studies reported that MCPIP1 protein levels in T cells were decreased in response to anti-CD3/CD28 antibody stimulation. 28, 34 Degradation and cleavage of MCPIP1 were abolished in the presence of a Malt1 protease inhibitor, as well as in Bcl10-or Malt1-deficient CD4 1 T cells, indicating that MCPIP1 is cleaved by Malt1. 28 Inhibition of Malt1 activity leads to reduction of IL-5/ IL-13 expression in WT CD4 T cells but not in Zc3h12a 2/2 CD4 T cells, indicating that the Malt1/MCPIP1 axis mainly regulates the development of IL-5/IL-13-producing T H 2 cells. IL-5 expression is known to be more dependent on expression levels of Gata3 than IL-4. 56, 57 In T-cell transfer experiments MCPIP1-deficient T H 2 cells were capable of causing enhanced airway inflammation and accumulation of T H 2 cytokine-producing cells with a memory phenotype. It was reported that treatment of MCPIP1-deficient mice with antibiotics increased survival and reduced mRNA levels of inflammatory cytokines, 58 suggesting a role of the microbiota in MCPIP1-mediated inflammation. MCPIP1 selectively targets the mRNAs encoding the T H 2 cytokines IL-5 and IL-13 for degradation (data not shown). Why MCPIP1 selectively targets specific cytokines, especially those associated with T H 2 cell differentiation and function, requires further investigation.
Although the role of Gata3 in regulating T H 2 cytokines is well established, 59 the mechanisms that suppress Gata3 expression have not been fully defined. Gata3 can be induced through TCR, IL-4 receptor/STAT6, IL-2 receptor/STAT5, and Notch signaling during T H 2 differentiation. Our work reveals high levels of Gata3 in Zc3h12a 2/2 CD4 T cells, and MCPIP1 promotes Gata3 mRNA decay through the RNase domain. We provide strong evidence indicating that MCPIP1 directly regulates Gata3 by binding to its 39 UTR for mRNA destabilization. Blonska et al 60 showed that Caspase recruitment domain-containing MAGUK protein 1 (CARMA1) upregulates Gata3 on the transcriptional level independent of nuclear factor kB activation. Given the fact that MCPIP1 is cleaved by Malt1, upregulation of Gata3 by CARMA1 might involve cleavage of MCPIP1 by the CARMA1-BCL10-MALT1 complex.
Based on our results, we propose the following model of T H 2 cell development regulated by MCPIP1. MCPIP1 inhibits T H 2 cell development by binding to the mRNAs encoding multiple T H 2 transcription factors, including Gata3, and by inhibiting T H 2-associated Notch signaling. On T-cell activation, MCPIP1 levels are reduced, and therefore releases its suppression on the T H 2 transcription factor and Notch pathway, which allows Gata3 to bind to the Il5 and Il13 gene loci, resulting in IL-5 1 / IL-13
1 T H 2 cell differentiation. Meanwhile, reductions in MCPIP1 levels increase the mRNA stability of Il5 and Il13. A combination of the increased T H 2 differentiation and T H 2 cytokine transcripts leads to enhanced T H 2 development and T H 2 effector function. Therefore strategies that increase MCPIP1 levels will inhibit IL-5 1 /IL-13
1 T H 2 cell differentiation and effector function, resulting in suppression of T H 2-mediated inflammation.
We thank Jonathan M. Kurie (University of Texas MD Anderson Cancer Center) for providing the Gata3 39 UTR luciferase constructs and Mingui Fu (University of Missouri Kansas City) for providing the MCPIP1 expression constructs.
Key messages
d MCPIP1 specifically inhibits IL-5/IL-13-producing T H 2 cell differentiation and function.
d MCPIP1 suppresses early differentiation of IL-5-producing T H 2 cells through Notch.
METHODS
Antibodies and flow cytometry
For surface staining, cells were stained at 48C in the presence of Fc Block (2.4G2; BD Biosciences, San Jose, Calif) in flow cytometry buffer (Dulbecco-PBS plus 2% FCS). After staining surface markers, cells were fixed and permeabilized for intracellular cytokine and transcription factor staining, according to the manufacturer's instructions (BD Biosciences). Antibodies used for surface and intracellular staining are listed in Table E2 .
T-cell lentiviral transduction
The lentiviral vector Gata3 shRNA and scramble shRNA were purchased from Sigma. Lentivirus was produced in HEK293T cells. CD4
1 T cells were stimulated for 24 hours with plate-bound anti-CD3 antibody (0.5 mg/ mL) and then transduced with virus-containing medium supplemented with polybrene (8 mg/mL). Twenty hours later, culture medium was replaced with complete medium with anti-CD3 antibody (0.5 mg/mL) for 2 days, rested for 2 days, and then stimulated with PMA and ionomycin for 4 hours for intracellular staining.
T-cell stimulation
Mouse CD4 1 T cells were negatively purified and activated by plate-coated anti-CD3 (1 mg/mL) and anti-CD28 (1 mg/mL) antibodies for 72 hours in complete cell medium (RPMI 1640) supplemented with 10% heat-inactivated FBS, 2 mmol/L glutamine, penicillin-streptomycin, nonessential amino acids, sodium pyruvate, 10 mmol/L HEPES, and 50 mmol/L 2-mercaptoethanol and then expanded for another 3 days in fresh medium containing 1 ng/mL recombinant mouse IL-2. In some experiments cells were cultured for 3 days, and supernatants were collected for measuring cytokines by means of ELISA. For isolation of infiltrating cells from lungs, lungs were minced and digested in 5 mL of RPMI 1640 media plus 10% FBS with 250 mg/mL collagenase IV (Roche, Mannheim, Germany) and 30 U/mL DNase I (SigmaAldrich) for 60 minutes at 378C with shocking. Cells were passed through a 70-mm strainer and spun down. The cell pellet was resuspended in 40% Percoll, layered carefully onto 80% Percoll, and centrifuged at 650g without a brake at room temperature for 30 minutes, and then the layer in the interface between the 2 Percoll concentrations was collected. Cells were washed with PBS before red blood cells were lysed with ACK lysis buffer. Cells were counted, and 2 3 10 6 cells were activated with PMA and ionomycin for analysis of intracellular cytokines and surface markers by using flow cytometry.
Tet-On System
WT or mutant MCPIP1 (D141N, C306R, and D225/226A) expressing CEM Tet-on cells was generated, as described previously.
E1 Cells were cultured for 24 hours with doxycycline (100 ng/mL) and then treated with PMA (10 ng/mL) and ionomycin (0.5 mg/mL) for 4 hours. Total RNA was isolated and used to measure gene expression. For Western blotting, CEM Tet-On cells were treated with doxycycline (100 ng/mL) for 48 hours and then lysed.
Luciferase assay
CEM-Tet-on cells were transfected with luciferase reporter plasmid containing the 39 UTR of Gata3 E2 by using Nucleofector (Lonza, Basel, Switzerland). MCPIP1 expression was induced by doxycycline (100 ng/ mL). Cells were lysed after 24 hours, and luciferase activity in lysates was determined by using the Dual-Luciferase Reporter Assay System (Promega, Madison, Wis).
Quantitative RT-PCR
Quantitative PCR was performed with SYBR green (Invitrogen, Life Technologies, Grand Island, NY) by using an Applied Biosystems StepOne PCR System (Applied Biosystems, Foster City, Calif). Results were analyzed with the DD cycle threshold method with glyceraldehyde-3-phosphate dehydrogenase as an endogenous reference control. Primer sequences are listed in Table E1 .
ELISA
Cell-culture supernatants were assayed by means of ELISA for mouse IL-4, IFN-g (BD Biosciences), IL-5, and IL-13 (eBioscience), according to the manufacturers' instructions.
RNA Immunoprecipitation
T H 2-polarized cell lysates were prepared from WT mice after 6 days of in vitro polarization. Cell lysates were prepared in NT-2 buffer (50 mmol/L Tris-HCl [pH 7.4], 150 mmol/L NaCl, 1 mmol/L MgCl 2 , and 0.05% NP-40) supplemented with 1 mmol/L dithiothreitol, 0.25 U/mL RNase out, and 13 protease inhibitor and incubated on ice for 10 minutes. Cell lysates were obtained after high-speed centrifugation at 15,000g for 15 minutes. Equal amounts of lysates were used for immunoprecipitation with MCPIP1 antibody and IgG 1 control. Anti-MCPIP1 antibody or IgG 1 was precoated on protein A Sepharose beads and incubated with cell lysates. Protein A Sepharose beads were then washed with NT-2 buffer and incubated with 20 U of RNase-free DNase I (15 minuets at 308C) and further incubated in 100 mL of NT-2 buffer containing 0.1% SDS and 0.5 mg/mL proteinase K (30 minutes at 558C). Total RNAs were isolated by adding TRIzol reagent (Invitrogen) to the beads, and quantitative PCR was performed to measure glyceraldehyde-3-phosphate dehydrogenase and Gata3 expression.
Histologic analysis
Peribronchiolar and perivascular inflammation were determined by using a semiquantitatively graded scale as follows: 0, no inflammation; 1, mild inflammation; 2, moderate inflammation; and 3, severe inflammation. Goblet cell hyperplasia was assessed as follows: 0, no or rare PAS 1 cells; 1, less than 10% PAS 1 cells observed at a magnification of 310; 2, 10% to 25% PAS 1 cells observed at a magnification of 310; and 3, greater than 25% PAS 1 cells observed at a magnification of 34. A composite score was determined by means of multiplication of the graded score and the frequency of airways or vessels with a given pathologic finding. All slides were examined in a random order and scored by a blinded pathologist. 5 3) . B, Total CD4 1 T cells of WT and Zc3h12a 2/2 mice were pretreated with GSI and then cultured with anti-CD3/CD28 antibodies. Cytokine-producing cells were gated on CD4 and summarized (n 5 3). *P < .05, **P < .01, and ***P < .001. Fig E7, A) , and inflammation was scored (Fig E7, B; ) cells gated on CD3 1 CD4 1 and CD3 1 CD4 2 cells. *P < .05, **P < .01, and ***P < .001. 
